Company Filing History:
Years Active: 2006-2025
Title: Wei Wang: Innovator in Galectin-3 Inhibitors
Introduction
Wei Wang is a prominent inventor based in Princeton, NJ (US), known for his significant contributions to the field of pharmaceutical sciences. He holds a total of 11 patents, showcasing his innovative approach to drug development and therapeutic solutions.
Latest Patents
Among his latest patents are groundbreaking compounds that inhibit Galectin-3, a protein implicated in various diseases. The first patent details compounds of Formula (I), which inhibit Gal-3 and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods for using and making these compounds and compositions. The second patent also focuses on small molecule inhibitors of Galectin-3, further emphasizing the importance of these compounds in medical research and treatment.
Career Highlights
Wei Wang is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Wei has collaborated with notable colleagues, including Pratik Devasthale and Chunjian Liu, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Wei Wang's contributions to the field of pharmaceutical innovation, particularly in the development of Galectin-3 inhibitors, highlight his role as a leading inventor. His ongoing work promises to yield significant advancements in therapeutic options for various diseases.